• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中西部阿米什人中,基于创始人群体特异性权重的多基因风险评分在阿尔茨海默病中的表现得到了改善。

Founder population-specific weights yield improvements in performance of polygenic risk scores for Alzheimer disease in the Midwestern Amish.

机构信息

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, USA.

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Cleveland Institute for Computational Biology, Case Western Reserve University, Cleveland, OH, USA.

出版信息

HGG Adv. 2023 Oct 12;4(4):100241. doi: 10.1016/j.xhgg.2023.100241. Epub 2023 Sep 22.

DOI:10.1016/j.xhgg.2023.100241
PMID:37742071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10565871/
Abstract

Alzheimer disease (AD) is the most common type of dementia and is estimated to affect 6 million Americans. Risk for AD is multifactorial, including both genetic and environmental risk factors. AD genomic research has generally focused on identification of risk variants. Using this information, polygenic risk scores (PRSs) can be calculated to quantify an individual's relative disease risk due to genetic factors. The Amish are a founder population descended from German and Swiss Anabaptist immigrants. They experienced a genetic bottleneck after arrival in the United States, making their genetic architecture different from the broader European ancestry population. Prior work has demonstrated the lack of transferability of PRSs across populations. Here, we compared the performance of PRSs derived from genome-wide association studies (GWASs) of Amish individuals to those derived from a large European ancestry GWAS. Participants were screened for cognitive impairment with further evaluation for AD. Genotype data were imputed after collection via Illumina genotyping arrays. The Amish individuals were split into two groups based on the primary site of recruitment. For each group, GWAS was conducted with account for relatedness and adjustment for covariates. PRSs were then calculated using weights from the other Amish group. PRS models were evaluated with and without covariates. The Amish-derived PRSs distinguished between dementia status better than the European-derived PRS in our Amish populations and demonstrated performance improvements despite a smaller training sample size. This work highlighted considerations for AD PRS usage in populations that cannot be adequately described by basic race/ethnicity or ancestry classifications.

摘要

阿尔茨海默病(AD)是最常见的痴呆症类型,据估计影响了 600 万美国人。AD 的风险是多因素的,包括遗传和环境风险因素。AD 的基因组研究通常侧重于识别风险变异。利用这些信息,可以计算多基因风险评分(PRS)来量化个体由于遗传因素导致的相对疾病风险。阿米什人是一个起源于德国和瑞士再洗礼派移民的创始人群体。他们抵达美国后经历了遗传瓶颈,这使得他们的遗传结构与更广泛的欧洲祖先群体不同。先前的工作表明 PRS 在人群之间的可转移性较差。在这里,我们比较了源自阿米什个体全基因组关联研究(GWAS)的 PRS 与源自大型欧洲祖先 GWAS 的 PRS 的性能。参与者通过进一步评估 AD 进行了认知障碍筛查。在通过 Illumina 基因分型阵列收集后,对基因型数据进行了 imputation。根据主要招募地点,将阿米什个体分为两组。对于每组,进行了 GWAS 分析,考虑了相关性并调整了协变量。然后使用另一个阿米什群体的权重计算 PRS。评估了有无协变量的 PRS 模型。在我们的阿米什人群中,与欧洲衍生的 PRS 相比,源自阿米什人群的 PRS 能更好地区分痴呆状态,并且尽管训练样本量较小,但表现仍有所改善。这项工作强调了在不能仅通过基本种族/民族或祖先分类来充分描述的人群中使用 AD PRS 时需要考虑的因素。

相似文献

1
Founder population-specific weights yield improvements in performance of polygenic risk scores for Alzheimer disease in the Midwestern Amish.在中西部阿米什人中,基于创始人群体特异性权重的多基因风险评分在阿尔茨海默病中的表现得到了改善。
HGG Adv. 2023 Oct 12;4(4):100241. doi: 10.1016/j.xhgg.2023.100241. Epub 2023 Sep 22.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Examining the Performance of Polygenic Risk Scores for Alzheimer Disease Within and Across Populations Using -Fold Cross-Validation.使用k折交叉验证法考察阿尔茨海默病多基因风险评分在人群内部和人群之间的表现。
Neurol Genet. 2024 Oct 23;10(6):e200198. doi: 10.1212/NXG.0000000000200198. eCollection 2024 Dec.
4
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.非洲裔人群中原发性开角型青光眼多基因风险评分的表现
JAMA Ophthalmol. 2025 Jan 1;143(1):7-14. doi: 10.1001/jamaophthalmol.2024.4784.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
7
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
8
Association of -Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.独立阿尔茨海默病多基因风险评分与无症状老年人大脑淀粉样蛋白沉积的关联。
Neurology. 2022 Aug 1;99(5):e462-e475. doi: 10.1212/WNL.0000000000200544.
9
Evaluating polygenic risk score prediction performance for Alzheimer's disease in a population-based Hispanic cohort using single- and multi-ancestry models.在一个基于人群的西班牙裔队列中,使用单祖先和多祖先模型评估阿尔茨海默病的多基因风险评分预测性能。
Lancet Reg Health Am. 2025 Jul 25;49:101198. doi: 10.1016/j.lana.2025.101198. eCollection 2025 Sep.
10
Multi-ancestry polygenic risk scores for venous thromboembolism.多血统多基因静脉血栓栓塞症风险评分。
Hum Mol Genet. 2024 Sep 3;33(18):1584-1591. doi: 10.1093/hmg/ddae097.

引用本文的文献

1
Examining the Performance of Polygenic Risk Scores for Alzheimer Disease Within and Across Populations Using -Fold Cross-Validation.使用k折交叉验证法考察阿尔茨海默病多基因风险评分在人群内部和人群之间的表现。
Neurol Genet. 2024 Oct 23;10(6):e200198. doi: 10.1212/NXG.0000000000200198. eCollection 2024 Dec.
2
Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset.阿尔茨海默病测序项目第4版全基因组测序数据集。
Alzheimers Dement. 2025 May;21(5):e70237. doi: 10.1002/alz.70237.
3
Alzheimer's Disease Sequencing Project Release 4 Whole Genome Sequencing Dataset.
阿尔茨海默病测序项目第4版全基因组测序数据集
medRxiv. 2024 Dec 6:2024.12.03.24317000. doi: 10.1101/2024.12.03.24317000.